Walker Walking

Your Impact

Funds raised through Rexall™ OneWalk to Conquer Cancer™ support Personalized Cancer Medicine research, treatment advances, education and new standards of care at The Princess Margaret and across Ontario.

To find out more about how The Princess Margaret is transforming cancer care for Canadians, download our handy infographic here.



1 in 2 Canadians will be diagnosed with cancer in their lifetime. That is a staggering and frightening statistic. As we celebrated the 16th year of walking to conquer cancer, we were reminded of the thousands of people, who just like you, laced up their running shoes, trained and fundraised in support of Princess Margaret Cancer Centre.

The funds you have helped to raise have allowed The Princess Margaret to become one of the top 5 cancer research centres in the world. Many of our world-leading researchers are making the impossible possible thanks to the tremendous philanthropic support that comes from our Walkers, donors, volunteers and supporters.

At The Princess Margaret, we are always pushing the envelope. We don’t just invent technology. We build the facilities and the processes needed to impact every aspect of cancer care. This has allowed us to explore completely personalized approaches where we take images of the patient just before treatment, design the plan for them and treat them in ways we could never have achieved before. We are also continuously adopting new methods, including the power of machine learning and artificial intelligence, to deliver precision medicine.

In 2019, OneWalk will kick off with OneWalk: City Nights on Friday, September 6, with a 15-kilometre Night Walk through downtown Toronto. Then on Saturday, September 7, participants will hit the road for our all-new OneWalk: Day Trip for a 25-kilometre Day Walk through one of Ontario’s most stunning landscapes.

I challenge you to lace up those sneakers, WALK ON with us and help Conquer Cancer In Our Lifetime.


Michael Burns
President & CEO

About The Princess Margaret

The 2018 Rexall™ OneWalk to Conquer Cancer™ raised $4.7 million. Since 2003, supporters of The Princess Margaret have walked to conquer cancer in all its forms. To date over $172 million has been raised.

Princess Margaret Cancer Centre is one of the top 5 cancer research centres in the world. We are the largest cancer research and clinical program in Canada. As global leaders in cancer care, we have the expertise to treat over 200 types of cancers including the rarest forms of the disease.

The Princess Margaret has a rich history of research excellence, discovery and innovation. Every day, we combine our clinical strength with the research expertise of The Campbell Family Cancer Research Institute to deliver breakthrough cancer research, treatments and patient-centered care.

Because we are Canada’s largest and most comprehensive cancer research centre, The Princess Margaret is responsible for delivering the evidence and measuring the benefit of new treatments and new approaches. We are proud to lead the way in the creation and delivery of the new gold standard in cancer care: Personalized Cancer Medicine.

This new model of patient care will allow us to detect cancer earlier, diagnose cancer with more precision, target treatment more effectively and support patients and families through their cancer journey. By leveraging our research and clinical strength, we will continue to lead the way and deliver the evidence that will create Personalized Cancer Medicine for patients at The Princess Margaret, across Canada and around the world.

The new discoveries and innovative cancer therapies that are changing cancer care for patients globally are happening right here in Canada at The Princess Margaret.

The Princess Margaret is

  • The world leader in cancer stem cell research
  • A world leader in image-guided therapeutics
  • A world leader in lung cancer research and treatment
  • A world leader in patient survivorship program development
  • An emerging leader in breast cancer research and discovery

The Princess Margaret offers comprehensive cancer care across 13 disease sites:

  • Breast
  • Lung
  • Gastrointestinal
  • Gynecologic
  • Genitourinary
  • Head and Neck
  • Central Nervous System
  • Lymphoma
  • Sarcoma
  • Leukemia
  • Eye
  • Endocrine
  • Skin

2017 By the Numbers:

  • The Princess Margaret treats over 200 types of cancer through surgery, chemotherapy, radiation, psychosocial and palliative care.
  • New patients: 17,751
  • Outpatient chemo visits: 37,754
  • Radiation visits: 91,517
  • Outpatient Clinic visits per day*: 1,652
  • Stem cell transplants: 416
  • Surgeries*: 6,031
  • *Approx. average based on five-day week

The Princess Margaret Cancer Centre is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute. All are research hospitals affiliated with the University of Toronto. For more information, go to www.uhn.ca.

Dollars at Work

The Rexall OneWalk to Conquer Cancer (formerly known as The Weekend to End Women’s Cancers) has made an enormous impact on the work of Princess Margaret Cancer Centre as highlighted below. As we walk in the Rexall™ OneWalk to Conquer Cancer™, the funds we raise will support world-leading research, new clinical and technological innovations, and the continuation of the important patient Survivorship program.


  • $54.7 million to The Campbell Family Institute for Breast Cancer Research led by Tak Mak with seven Principal Investigators, three Affiliate Scientists, one Emeritus Scientist and 112 staff.
    • Tak Mak and his team of researchers from The Campbell Family Research Institute announced a new “sharpshooter” cancer drug that will target an enzyme called PLK4, which plays a crucial role in the process of cancer cell division. On July 18, 2013 Dr. Mak and his team gained clearance by Health Canada to proceed with the drug into Phase I Clinical Trial in Canada.*
    • Scientists led by Drs. Mona Gauthier and Tak Mak have discovered how BRCA1 gene mutations specifically predispose women to breast and ovarian cancers.
    • Pamela Ohashi’s research into T-cell activation and boosting the immune system to fight tumors. Her work focuses on understanding the signaling pathways of T-cells to help activate, direct and enhance anti-tumor responses in cancer. Clinical trial of her team’s adoptive cell therapy began in the Fall of 2013. Dr. Pamela Ohashi’s research into T-cell activation and immunotherapy to fight breast tumours is part of The Campbell Family Institute funding.
  • $8.7 million to purchase cutting-edge research equipment and support breast cancer research activities in the PMH research expansion at MaRS (Medical and Related Science), including immunotherapy and stem cell biology.
  • $3 million to create The Weekend to End Breast Cancer Chair in Breast Cancer Research, held by Dr. Tak Mak, a world-renowned cancer research scientist.
  • $1.5 million to the Walker Innovation Program, which supports researchers and new ideas that have the potential for advancing scientific knowledge of breast cancer.
  • $2.1 million to support Dr. Norman Boyd’s research into breast cancer prevention, focusing on the understanding of mammographic density as a risk factor.
  • $1.8 million to support Mass Spectrometer program
  • $500,000 to support research at The Campbell Family Cancer Research Institute for equipment, lab expenses, research and staff related expenses and research operations.

Clinical Enhancements

  • $3.9 million toward a comprehensive breast imaging program and the purchase of a breast MRI and digital mammography.
  • $3 million toward a newly revamped and re-designed Lau Breast Centre that provides complete care for breast cancer patients.
  • $2.9 million to support clinical trials for breast cancer and $500,000 for the fellowship program.
  • $2 million to support an extensive Tumour Bank, database maintenance and pathology.
  • $1.3 million to support Dr. David McCready’s rapid diagnosis pilot study, which is now The Gattuso Rapid Diagnostic Centre and sees up to 1,500 patients a year.
  • $550,000 to support the clinical trial of intraoperative radiation therapy, led by David McCready and Dr. Anthony Fyles.
  • $250,000 toward the design and creation of the new Conway Chemotherapy and Transfusion Centre, the largest centre of its kind in North America.
  • $1.2 million to support the surgical robotics program for gynecologic  cancer patients.
  • $160,000 toward the Familial Ovarian Cancer Clinic, which now also provides genetic counselling for breast cancer.
  • $6.6 million for other clinical enhancements and other research programs.
  • $2.5 million to support The Princess Margaret’s Space Transformation, which is a multi-phase project that will create a transformative environment for Personalized Cancer Medicine.
  • $130,000 towards grant matching program


  • $11.8 million for the establishment and continued support of the first in-hospital Survivorship Clinic and Program in Canada. This includes ELLICSR, a 12,000-square-foot innovative research centre, and caringvoices.ca, an award-winning online community for survivors and their families.
  • $1 million to provide reconstructive breast surgery for women who have had breast cancer.

*New cancer drug development is a long and risk-filled process. We are very encouraged by this discovery and reaching this major milestone. The drug discovery from Dr. Tak Mak and Dr. Dennis Slamon announced by The Princess Margaret Cancer Foundation in June 2013 has been cleared by Health Canada and the University Health Network Research Ethics Board, and is in clinical trials. For more information, please visit  www.canadiancancertrials.ca.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search